Europe In-Vitro Diagnostics Market Outlook to 2018 - Ageing Demographic and Mounting Consolidations to Drive Future Growth
The report titled “Europe In-Vitro Diagnostics Market Outlook to 2018 - Ageing Demographic and Mounting Consolidation to Drive Future Growth” provides a comprehensive analysis of the various aspects such as market size of the Europe, Germany, France, Italy, Spain, and the UK in-vitro diagnostics market. The report also covers the segmentations of in-vitro diagnostic markets in several European countries by reagents, instruments; by IVD labs, auto-tests; and by private laboratories, public and private hospitals, wholesalers and dispatchers, blood transfusion centers and others. The market shares of major players in the Europe IVD space have also been provided along with the comprehensive overview of the future of the in-vitro diagnostics market in Europe.
In-vitro diagnostics market in Europe, which has majorly been driven by the increasing number of lifestyle diseases, inclining preventive healthcare practices, mounting disposable incomes, ageing population and improving healthcare infrastructure, registered revenues of USD ~ million in 2013. With an advent of new varieties of diagnostic tests incorporating latest technology, the industry revenues increased by ~% in 2013 as compared to 2012. In-vitro diagnostics market in Europe is subject to a gamut of different factors, such as people with diabetes, heart, kidney and other infectious and lifestyle diseases and the overall disposable incomes in several countries, which play an important role in determining the revenues from various diagnostic segments.
Reagents have been the largest contributing category in terms of revenue, having recorded the maximum sales over the years. The Europe in-vitro diagnostics market has grown at a CAGR of ~% from USD 13 billion in 2007 to USD ~ billion in 2013.
In vitro diagnostics market in Europe has showcased a gradual decline over the years. The market revenues have suffered owing to a gamut of factors. One of the major factors contributing to the weakened diagnostic market is principally linked to the stringent market setting and the austerity measures established to control healthcare costs. This has led to the consolidation of laboratories, strong price pressures, and delays of payment by healthcare authorities. These factors have cumulatively influenced the IVD industry negatively.
In-vitro diagnostics market in Europe has showcased several emerging trends over the past few years. Some of the most definitive of these trends has been the advent of decentralized testing, mounting automation in laboratories, increasing consolidation and preference for early detection of diseases. Several pathological labs have resorted to invest heftily and have been adopting fully automated systems for disease diagnosis. In light of this, the accuracy of test results has increased, while the turnaround times have declined significantly. Additionally, the growth of portable diagnostics devices has propelled the market for point of care testing in Europe.
The market for in-vitro diagnostics in Europe is changing at a brisk rate. Technological advancements, demand of diagnostic tests from an ever growing base of disease-ridden population and people suffering from lifestyle diseases, as well as the consolidations amongst diagnostic product manufacturers in a number of countries in Europe have been significantly changing the market. Revenues from in-vitro diagnostics market in Europe are projected to expand to USD ~ million in 2018, growing with a CAGR of ~% from 2013 to 2018.
KEY TOPICS COVERED IN THE REPORT
In-vitro diagnostics market in Europe, which has majorly been driven by the increasing number of lifestyle diseases, inclining preventive healthcare practices, mounting disposable incomes, ageing population and improving healthcare infrastructure, registered revenues of USD ~ million in 2013. With an advent of new varieties of diagnostic tests incorporating latest technology, the industry revenues increased by ~% in 2013 as compared to 2012. In-vitro diagnostics market in Europe is subject to a gamut of different factors, such as people with diabetes, heart, kidney and other infectious and lifestyle diseases and the overall disposable incomes in several countries, which play an important role in determining the revenues from various diagnostic segments.
Reagents have been the largest contributing category in terms of revenue, having recorded the maximum sales over the years. The Europe in-vitro diagnostics market has grown at a CAGR of ~% from USD 13 billion in 2007 to USD ~ billion in 2013.
In vitro diagnostics market in Europe has showcased a gradual decline over the years. The market revenues have suffered owing to a gamut of factors. One of the major factors contributing to the weakened diagnostic market is principally linked to the stringent market setting and the austerity measures established to control healthcare costs. This has led to the consolidation of laboratories, strong price pressures, and delays of payment by healthcare authorities. These factors have cumulatively influenced the IVD industry negatively.
In-vitro diagnostics market in Europe has showcased several emerging trends over the past few years. Some of the most definitive of these trends has been the advent of decentralized testing, mounting automation in laboratories, increasing consolidation and preference for early detection of diseases. Several pathological labs have resorted to invest heftily and have been adopting fully automated systems for disease diagnosis. In light of this, the accuracy of test results has increased, while the turnaround times have declined significantly. Additionally, the growth of portable diagnostics devices has propelled the market for point of care testing in Europe.
The market for in-vitro diagnostics in Europe is changing at a brisk rate. Technological advancements, demand of diagnostic tests from an ever growing base of disease-ridden population and people suffering from lifestyle diseases, as well as the consolidations amongst diagnostic product manufacturers in a number of countries in Europe have been significantly changing the market. Revenues from in-vitro diagnostics market in Europe are projected to expand to USD ~ million in 2018, growing with a CAGR of ~% from 2013 to 2018.
KEY TOPICS COVERED IN THE REPORT
- The market size of the Europe in-vitro diagnostics market.
- The market size of the Germany in-vitro diagnostics market.
- The market size of the France in-vitro diagnostics market.
- The market size of the Italy in-vitro diagnostics market.
- The market size of the Spain in-vitro diagnostics market.
- The market size of the UK in-vitro diagnostics market.
- Market segmentation of the Europe in-vitro diagnostics market on the basis of contribution from different countries in Europe.
- Market segmentation of Germany in-vitro diagnostics market on the basis of contribution from instruments and reagents, including contribution by reagents for different types of tests.
- Market segmentation of France in-vitro diagnostics market on the basis of contribution from IVD labs and auto-tests, reagents and instruments, and Private Laboratories, Public and Private Hospitals, Wholesalers and Dispatchers, Blood Transfusion Centers and Others.
- Market segmentation of Spain in-vitro diagnostics market on the basis of contribution from IVD labs, auto-tests, POCT and IT software, and reagents and instruments, as well as on the basis of reagents used in different types of tests.
- Market segmentation of Italy in-vitro diagnostics market on the basis of contribution from Reagents, Laboratories, Kits and Others.
- Market segmentation of the UK in-vitro diagnostics laboratory market on the basis of contribution from different types of tests.
- Growth drivers for the in-vitro diagnostics market in Germany, France, Italy, Spain and the UK.
- Market Share of major players in Europe in-vitro diagnostic market (Roche, Abbott, Siemens, BioMerieux, Becton and Dickinson, Johnson & Johnson, Sysmex)
- Trends and Development in the Europe in-vitro diagnostics market.
- Future outlook and projections of the Europe, Germany, France, Spain, Italy and the UK in-vitro diagnostics market.
1. EUROPE IN-VITRO DIAGNOSTICS MARKET INTRODUCTION
Germany
France
Italy
Spain
UK
1.1. Europe In-Vitro Diagnostics Market Regulations
2. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, 2007-2013
3. EUROPE IN-VITRO DIAGNOSTICS MARKET SEGMENTATION BY GEOGRAPHY, 2007-2013
Germany
France
Italy
Spain
The UK
3.1. Germany In-Vitro Diagnostics Market Segmentation by Reagents and Instruments, 2007-2013
3.2. Germany In-Vitro Diagnostics Market Growth Drivers
3.2.1. Ageing Population of 45 Years and Above and Rising Disposable Income in Germany, 2007-2018
3.2.2. Increasing Consumer Expenditure on Healthcare in Germany, 2007-2018
3.2.3. Surging Healthcare Investments in Germany, 2007-2018
3.3. France In-Vitro Diagnostics Market Segmentation
3.3.1. By IVD Labs and Auto-Tests, 2007-2013
3.3.2. By Reagents and Instruments, 2007-2013
3.3.3. By Private Laboratories, Public and Private Hospitals, Wholesalers and Dispatchers, Blood Transfusion Centers and Others, 2006-2012
3.4. France In-Vitro Diagnostics Market Growth Drivers
3.4.1. Ageing Population of 65 Years and Above and Increasing Disposable Income in France, 2007-2018
3.4.2. Increasing Public and Private Expenditure on Healthcare in France, 2007-2018
3.4.3. Increasing Expenditure on Medical and Pharmaceutical Research in France, 2007-2018
3.5. Italy In-Vitro Diagnostics Market Segmentation by Reagents, Laboratories, Kits and Others, 2012
3.6. Italy In-Vitro Diagnostics Market Growth Drivers
3.6.1. Increasing Ageing Population of 65 Years and Above and Mounting Disposable Incomes in Italy, 2007-2018
3.6.2. Increasing Public and Private Healthcare Expenditure in Italy, 2007-2018
3.7. Spain In-Vitro Diagnostics Market Segmentation
3.7.1. By IVD Labs, Auto-Tests, POCT and IT Software, 2012
3.7.2. By Reagents and Instruments, 2012
3.7.3. By Type of Tests, 2012
3.8. Spain In-Vitro Diagnostics Market Shares of Major Players, 2012
3.9. Spain In-Vitro Diagnostics Growth Drivers
3.9.1. Increasing Population of 65 Years and Above and Inclining Disposable Income in Spain, 2007-2018
3.9.2. Increasing Public and Private Healthcare Expenditure in Spain, 2007-2018
3.10. The UK In-Vitro Diagnostics Laboratory Market Segmentation by Types of Tests, 2012
3.11. The UK In-Vitro Diagnostics Market Growth Drivers
3.11.1. Increasing Population of 65 Years and Above and Increasing Disposable Income in the UK, 2007-2018
Healthcare Expenditure in the UK, 2007-2018
4. EUROPE IN-VITRO DIAGNOSTICS MARKET TRENDS AND DEVELOPMENTS
5. MARKET SHARE OF MAJOR PLAYERS IN EUROPE IN-VITRO DIAGNOSTICS MARKET, 2010-2013
6. COMPANY PROFILES OF MAJOR PLAYERS IN THE EUROPE IN-VITRO DIAGNOSTICS MARKET
7. EUROPE IN-VITRO DIAGNOSTICS MARKET FUTURE OUTLOOK AND PROJECTIONS, 2014-2018
7.1. Cause and Effect Relationship Analysis of the In-vitro Diagnostics Market in Europe
8. APPENDIX
8.1. Market Definitions
8.2. Abbreviations
8.3. Research Methodology
Data Collection Methods
Approach
Variables (Dependent and Independent)
Final Conclusion
8.4. Disclaimer
Germany
France
Italy
Spain
UK
1.1. Europe In-Vitro Diagnostics Market Regulations
2. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, 2007-2013
3. EUROPE IN-VITRO DIAGNOSTICS MARKET SEGMENTATION BY GEOGRAPHY, 2007-2013
Germany
France
Italy
Spain
The UK
3.1. Germany In-Vitro Diagnostics Market Segmentation by Reagents and Instruments, 2007-2013
3.2. Germany In-Vitro Diagnostics Market Growth Drivers
3.2.1. Ageing Population of 45 Years and Above and Rising Disposable Income in Germany, 2007-2018
3.2.2. Increasing Consumer Expenditure on Healthcare in Germany, 2007-2018
3.2.3. Surging Healthcare Investments in Germany, 2007-2018
3.3. France In-Vitro Diagnostics Market Segmentation
3.3.1. By IVD Labs and Auto-Tests, 2007-2013
3.3.2. By Reagents and Instruments, 2007-2013
3.3.3. By Private Laboratories, Public and Private Hospitals, Wholesalers and Dispatchers, Blood Transfusion Centers and Others, 2006-2012
3.4. France In-Vitro Diagnostics Market Growth Drivers
3.4.1. Ageing Population of 65 Years and Above and Increasing Disposable Income in France, 2007-2018
3.4.2. Increasing Public and Private Expenditure on Healthcare in France, 2007-2018
3.4.3. Increasing Expenditure on Medical and Pharmaceutical Research in France, 2007-2018
3.5. Italy In-Vitro Diagnostics Market Segmentation by Reagents, Laboratories, Kits and Others, 2012
3.6. Italy In-Vitro Diagnostics Market Growth Drivers
3.6.1. Increasing Ageing Population of 65 Years and Above and Mounting Disposable Incomes in Italy, 2007-2018
3.6.2. Increasing Public and Private Healthcare Expenditure in Italy, 2007-2018
3.7. Spain In-Vitro Diagnostics Market Segmentation
3.7.1. By IVD Labs, Auto-Tests, POCT and IT Software, 2012
3.7.2. By Reagents and Instruments, 2012
3.7.3. By Type of Tests, 2012
3.8. Spain In-Vitro Diagnostics Market Shares of Major Players, 2012
3.9. Spain In-Vitro Diagnostics Growth Drivers
3.9.1. Increasing Population of 65 Years and Above and Inclining Disposable Income in Spain, 2007-2018
3.9.2. Increasing Public and Private Healthcare Expenditure in Spain, 2007-2018
3.10. The UK In-Vitro Diagnostics Laboratory Market Segmentation by Types of Tests, 2012
3.11. The UK In-Vitro Diagnostics Market Growth Drivers
3.11.1. Increasing Population of 65 Years and Above and Increasing Disposable Income in the UK, 2007-2018
Healthcare Expenditure in the UK, 2007-2018
4. EUROPE IN-VITRO DIAGNOSTICS MARKET TRENDS AND DEVELOPMENTS
5. MARKET SHARE OF MAJOR PLAYERS IN EUROPE IN-VITRO DIAGNOSTICS MARKET, 2010-2013
6. COMPANY PROFILES OF MAJOR PLAYERS IN THE EUROPE IN-VITRO DIAGNOSTICS MARKET
7. EUROPE IN-VITRO DIAGNOSTICS MARKET FUTURE OUTLOOK AND PROJECTIONS, 2014-2018
7.1. Cause and Effect Relationship Analysis of the In-vitro Diagnostics Market in Europe
8. APPENDIX
8.1. Market Definitions
8.2. Abbreviations
8.3. Research Methodology
Data Collection Methods
Approach
Variables (Dependent and Independent)
Final Conclusion
8.4. Disclaimer
LIST OF FIGURES
Figure 1: Europe In-Vitro Diagnostics Regulations
Figure 2: Europe In-Vitro Diagnostics Market Size on the Basis of Revenues in USD Million, 2007-2013
Figure 3: Europe In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from Different Countries in Percentage, 2007-2013
Figure 4: Germany In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, 2007-2013
Figure 5: Germany In-Vitro Diagnostics Reagents Market Segmentation on the Basis of Revenues from Different Tests in Percentage, 2007-2013
Figure 6: Population of 45 Years and Above in Germany in Million, 2007-2018
Figure 7: Disposable Income in Germany in USD Million, 2007-2018
Figure 8: Consumer Expenditure on Healthcare in Germany in USD Million, 2007-2018
Figure 9: Diabetes Cases in the Population Group of 20-79 Years in Germany in Thousands, 2010-2013
Figure 10: Investments in Healthcare by Healthcare Facilities in Germany in USD Million, 2007-2018
Figure 11: France In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from IVD Labs and Auto-Tests in Percentage, 2007-2013
Figure 12: Diabetes Cases in the Population Group of 20-79 Years in France in Thousands, 2010-2013
Figure 13: France In-Vitro Diagnostics Laboratory Market Segmentation by Revenues from Reagents and Instruments in Percentage, 2007-2013
Figure 14: France In-Vitro Diagnostic Reagents Market Segmentation on the Basis of Revenues from Reagents Used in Different Tests in Percentage, 2007-2013
Figure 15: France In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from Private Labs, Public and Private Hospitals, Wholesalers and Dispatchers, Blood Transfusion Centers and Others in Percentage, 2006-2012
Figure 16: Population in France in Million, 2007-2018
Figure 17: Disposable Income in France in USD Million, 2007-2018
Figure 18: Public and Private Expenditure on Healthcare in France in USD Million, 2007-2018
Figure 19: Expenditure on Medical and Pharmaceutical Research In France in USD Million, 2007-2018
Figure 20: Italy In-Vitro Diagnostics Market Segmentation on the Basis of Revenue Contribution from Reagents, Laboratories, Kits and Others in Percentage, 2012
Figure 21: Diabetes Cases in the Population Group of 20-79 Years in Italy in Thousands, 2010-2013
Figure 22: Population in Italy in Million, 2007-2018
Figure 23: Disposable Income in Italy in USD Million, 2007-2018
Figure 24: Public and Private Healthcare Expenditure in Italy in USD Million, 2007-2018
Figure 25: Spain In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from IVD Labs, Auto-Tests, POCT and IT Software in Percentage, 2012
Figure 26: Diabetes Cases in the Population Group of 20-79 Years in Spain in Thousands, 2010-2013
Figure 27: Spain In-Vitro Diagnostics Laboratory Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, 2012
Figure 28: Spain In-Vitro Diagnostic Reagents Market Segmentation on the Basis of Revenues from Different Tests in Percentage, 2012
Figure 29: Market Shares of Major Players on the Basis of Revenues in Spain In-Vitro Diagnostics Market in Percentage, 2012
Figure 30: Population in Spain in Million, 2007-2018
Figure 31: Disposable Income in Spain in USD Million, 2007-2018
Figure 32: Public and Private Healthcare Expenditure in Spain in USD Million, 2007-2018
Figure 33: The UK In-Vitro Diagnostics Laboratory Market Segmentation on the Basis of Revenues from Different Types of Tests in Percentage, 2012
Figure 34: Population in the UK in Million, 2007-2018
Figure 35: Disposable Income per Head in the UK, 2007-2018
Figure 36: Healthcare Expenditure in the UK in USD Million, 2007-2018
Figure 1: Europe In-Vitro Diagnostics Regulations
Figure 2: Europe In-Vitro Diagnostics Market Size on the Basis of Revenues in USD Million, 2007-2013
Figure 3: Europe In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from Different Countries in Percentage, 2007-2013
Figure 4: Germany In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, 2007-2013
Figure 5: Germany In-Vitro Diagnostics Reagents Market Segmentation on the Basis of Revenues from Different Tests in Percentage, 2007-2013
Figure 6: Population of 45 Years and Above in Germany in Million, 2007-2018
Figure 7: Disposable Income in Germany in USD Million, 2007-2018
Figure 8: Consumer Expenditure on Healthcare in Germany in USD Million, 2007-2018
Figure 9: Diabetes Cases in the Population Group of 20-79 Years in Germany in Thousands, 2010-2013
Figure 10: Investments in Healthcare by Healthcare Facilities in Germany in USD Million, 2007-2018
Figure 11: France In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from IVD Labs and Auto-Tests in Percentage, 2007-2013
Figure 12: Diabetes Cases in the Population Group of 20-79 Years in France in Thousands, 2010-2013
Figure 13: France In-Vitro Diagnostics Laboratory Market Segmentation by Revenues from Reagents and Instruments in Percentage, 2007-2013
Figure 14: France In-Vitro Diagnostic Reagents Market Segmentation on the Basis of Revenues from Reagents Used in Different Tests in Percentage, 2007-2013
Figure 15: France In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from Private Labs, Public and Private Hospitals, Wholesalers and Dispatchers, Blood Transfusion Centers and Others in Percentage, 2006-2012
Figure 16: Population in France in Million, 2007-2018
Figure 17: Disposable Income in France in USD Million, 2007-2018
Figure 18: Public and Private Expenditure on Healthcare in France in USD Million, 2007-2018
Figure 19: Expenditure on Medical and Pharmaceutical Research In France in USD Million, 2007-2018
Figure 20: Italy In-Vitro Diagnostics Market Segmentation on the Basis of Revenue Contribution from Reagents, Laboratories, Kits and Others in Percentage, 2012
Figure 21: Diabetes Cases in the Population Group of 20-79 Years in Italy in Thousands, 2010-2013
Figure 22: Population in Italy in Million, 2007-2018
Figure 23: Disposable Income in Italy in USD Million, 2007-2018
Figure 24: Public and Private Healthcare Expenditure in Italy in USD Million, 2007-2018
Figure 25: Spain In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from IVD Labs, Auto-Tests, POCT and IT Software in Percentage, 2012
Figure 26: Diabetes Cases in the Population Group of 20-79 Years in Spain in Thousands, 2010-2013
Figure 27: Spain In-Vitro Diagnostics Laboratory Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, 2012
Figure 28: Spain In-Vitro Diagnostic Reagents Market Segmentation on the Basis of Revenues from Different Tests in Percentage, 2012
Figure 29: Market Shares of Major Players on the Basis of Revenues in Spain In-Vitro Diagnostics Market in Percentage, 2012
Figure 30: Population in Spain in Million, 2007-2018
Figure 31: Disposable Income in Spain in USD Million, 2007-2018
Figure 32: Public and Private Healthcare Expenditure in Spain in USD Million, 2007-2018
Figure 33: The UK In-Vitro Diagnostics Laboratory Market Segmentation on the Basis of Revenues from Different Types of Tests in Percentage, 2012
Figure 34: Population in the UK in Million, 2007-2018
Figure 35: Disposable Income per Head in the UK, 2007-2018
Figure 36: Healthcare Expenditure in the UK in USD Million, 2007-2018
LIST OF TABLES
Table 1: Europe In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from Different Countries in USD Million, 2007-2013
Table 2: Per Capita Spending in IVD in Europe in USD and IVD Market as a Percentage of Total Healthcare Expenditure in Europe, 2012
Table 3: Germany In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from Reagents and Instruments in USD Million, 2007-2013
Table 4: Germany In-Vitro Diagnostics Reagents Market Segmentation on the Basis of Revenues from Different Tests in USD Million, 2007-2013
Table 5: France In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from IVD Labs and Auto-Tests in USD Million, 2007-2013
Table 6: France In-Vitro Diagnostics Laboratory Market Segmentation by Revenues from Reagents and Instruments in USD Million, 2007-2013
Table 7: France In-Vitro Diagnostic Reagents Market Segmentation on the Basis of Revenues from Reagents Used in Different Tests in USD Million, 2007-2013
Table 8: Number of Diagnostic Laboratories in Metropolitan France and their Growth in Percentage, 2006-2012
Table 9: Percentage of Aging Population in Major IVD Markets in Europe, 1991 and 2011
Table 10: Market Shares of Major Players in Europe In-Vitro Diagnostics Market on the Basis of Revenues in Percentage, 2010-2013
Table 11: Revenues of Major Players in Europe In-Vitro Diagnostics Market in USD Million, 2010-2013
Table 12: Company Profiles of Major Players in the Europe In-Vitro Diagnostics Market
Table 13: Europe In-Vitro Diagnostics Future Projections on the Basis of Revenues from Different Countries in USD Million, 2014-2018
Table 14: Europe In-Vitro Diagnostics Future Projections on the Basis of Revenues from Different Countries in Percentage, 2014-2018
Table 15: Cause and Effect Relationship Analysis between Industry Factors and Expected In-Vitro Diagnostics Market Prospects in Europe
Table 16: Correlation Matrix of the France In-Vitro Diagnostics Market
Table 17: Regression Coefficients Output
Table 1: Europe In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from Different Countries in USD Million, 2007-2013
Table 2: Per Capita Spending in IVD in Europe in USD and IVD Market as a Percentage of Total Healthcare Expenditure in Europe, 2012
Table 3: Germany In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from Reagents and Instruments in USD Million, 2007-2013
Table 4: Germany In-Vitro Diagnostics Reagents Market Segmentation on the Basis of Revenues from Different Tests in USD Million, 2007-2013
Table 5: France In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from IVD Labs and Auto-Tests in USD Million, 2007-2013
Table 6: France In-Vitro Diagnostics Laboratory Market Segmentation by Revenues from Reagents and Instruments in USD Million, 2007-2013
Table 7: France In-Vitro Diagnostic Reagents Market Segmentation on the Basis of Revenues from Reagents Used in Different Tests in USD Million, 2007-2013
Table 8: Number of Diagnostic Laboratories in Metropolitan France and their Growth in Percentage, 2006-2012
Table 9: Percentage of Aging Population in Major IVD Markets in Europe, 1991 and 2011
Table 10: Market Shares of Major Players in Europe In-Vitro Diagnostics Market on the Basis of Revenues in Percentage, 2010-2013
Table 11: Revenues of Major Players in Europe In-Vitro Diagnostics Market in USD Million, 2010-2013
Table 12: Company Profiles of Major Players in the Europe In-Vitro Diagnostics Market
Table 13: Europe In-Vitro Diagnostics Future Projections on the Basis of Revenues from Different Countries in USD Million, 2014-2018
Table 14: Europe In-Vitro Diagnostics Future Projections on the Basis of Revenues from Different Countries in Percentage, 2014-2018
Table 15: Cause and Effect Relationship Analysis between Industry Factors and Expected In-Vitro Diagnostics Market Prospects in Europe
Table 16: Correlation Matrix of the France In-Vitro Diagnostics Market
Table 17: Regression Coefficients Output
